Funding for this research was provided by:
Bayerisches Staatsministerium für Bildung und Kultus, Wissenschaft und Kunst (ForIPS)
Regensburger Forschungsförderung in der Medizin (ReForM A-Grant)
Received: 14 December 2017
Accepted: 26 April 2018
First Online: 3 May 2018
Ethics approval and consent to participate
: Human primary stem-like glioblastoma cell lines (NCH1425, NCH421k, NCH465, NCH601, NCH644) were obtained from patients undergoing surgical resection at the Neurosurgical Department of Heidelberg University Hospital according to the research proposals approved by the Institutional Review Board at the Medical Faculty Heidelberg (CHM). Written consent was obtained from each patient.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.